These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Pentoxifylline and prostaglandins]. Poggesi L, Boddi M, Scarti L, Masotti G. Ric Clin Lab; 1988; 18 Suppl 2():37-46. PubMed ID: 2854659 [No Abstract] [Full Text] [Related]
4. The release of prostacyclin (PGI2) by pentoxifylline from human vascular tissue. Matzky R, Darius H, Schrör K. Arzneimittelforschung; 1982; 32(10):1315-8. PubMed ID: 6817760 [Abstract] [Full Text] [Related]
9. Effect of pentoxifylline on platelet aggregation. Nenci GG, Gresele P, Agnelli G, Ballatori E. Pharmatherapeutica; 1981 Apr; 2(8):532-8. PubMed ID: 7255510 [Abstract] [Full Text] [Related]
10. Effects of furosemide on prostacyclin-like antiaggregatory release from vessel wall and renal cortex. Weithmann KU. Pharmacol Res Commun; 1982 May; 14(5):391-9. PubMed ID: 7051051 [No Abstract] [Full Text] [Related]
11. Studies on platelet aggregation inhibitors in vivo. VIII. Effect of pentoxifylline on spontaneous tumor metastasis. Gordon S, Witul M, Cohen H, Sciandra J, Williams P, Gastpar H, Murphy GP, Ambrus JL. J Med; 1979 May; 10(6):435-43. PubMed ID: 233697 [Abstract] [Full Text] [Related]
12. Studies on platelet aggregation inhibitors in vivo. X. Relationship to thrombolysis. Ambrus JL, Ambrus CM, Sharma SD, Suh OW, Gastpar H. J Med; 1982 May; 13(5-6):365-71. PubMed ID: 6221055 [Abstract] [Full Text] [Related]
13. Platelet resistance to prostacyclin. Enhancement of the antiaggregatory effect of prostacyclin by pentoxifylline. Manrique RV, Manrique V. Angiology; 1987 Feb; 38(2 Pt 1):101-8. PubMed ID: 3030162 [Abstract] [Full Text] [Related]
14. Studies on platelet aggregation in vivo. VII: Effect of pentoxyfylline on circulating tumor cells. Gastpar H, Ambrus JL, Ambrus CM. J Med; 1978 Feb; 9(3):265-8. PubMed ID: 283171 [Abstract] [Full Text] [Related]
15. Prostacyclin production by rat aorta "in vitro" is increased by the combined action of dipyridamole plus pentoxifylline. Santos MT, Martinez-Sales V, Vallés J, Aznar J, Yaya R, Vayá A, Villa P. Prostaglandins; 1985 Jan; 29(1):113-22. PubMed ID: 3919421 [Abstract] [Full Text] [Related]
16. Mechanism of the potentiation of thrombolysis by pentoxifylline (Trental). Ambrus JL, Ambrus CM, Mahfzah M, Markus JA, Klein E, Gastpar H. J Med; 1987 Jan; 18(5-6):265-76. PubMed ID: 3505256 [Abstract] [Full Text] [Related]
17. Studies on vasoocclusive crisis of sickle cell disease. I. Effect of pentoxifylline. Ambrus JL, Ambrus CM, Gastpar H, Bannerman R, Bettigole R, Friedman S. J Med; 1979 Jan; 10(6):445-56. PubMed ID: 299453 [Abstract] [Full Text] [Related]
18. Antithrombotic potential of pentoxifylline. A hemorheologically active drug. Schröer RH. Angiology; 1985 Jun; 36(6):387-98. PubMed ID: 3927788 [Abstract] [Full Text] [Related]
19. Lack of pharmacodynamic interaction between pentoxifylline and warfarin in the rat. Luke DR, O'Donnell MP, Keane WF, Matzke GR. Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):65-72. PubMed ID: 3797806 [Abstract] [Full Text] [Related]